Gout patients taking Benzbromarone hurt again may be caused by the fluctuation of uric acid levels in the joints due to the leaching of uric acid from the tissues during the initial phase of treatment. Benzbromarone can control uric acid level by promoting uric acid excretion, used in the treatment of primary hyperuricemia, gouty nodules and gouty intervals, etc. In the initial treatment stage of Benzbromarone, due to the leaching of uric acid from tissues, the use of patients with acute gout may exacerbate the pain symptoms. Therefore, the use of uric acid-lowering drugs such as benzbromarone should be avoided during acute gouty attacks. Benzbromarone needs to be used under the guidance of a physician, and gout patients are advised to go to the hospital in time for treatment under the guidance of a doctor.